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Abstract
Triclosan is an antimicrobial commonly used in many different antiseptics and
everyday products. Unfortunately, many bacteria are now resistant to triclosan due to
innate resistance, mutations in the fabI gene, and/or overexpression of certain other genes
(soxS, marA, and an efflux pump encoded by acrAB). Therefore, it is essential that drugs
be developed to destroy bacteria now resistant to triclosan. In this experiment, four
different derivatives of triclosan were tested for antibacterial capabilities under the
supervision of Dr. Hubbard at Liberty University. The derivatives were synthesized by
Professor McGibbon (professor of organic chemistry at LU). Solutions of 4.0 ug/mL of
each derivative were made and then tested against S. aureus for inhibition capabilities.
Some of the derivatives seemed to have some inhibition capabilities, but none of them
were as inhibitive as triclosan itself. Of special note, some of the results seem to indicate
that the added benzene ring may inactivate triclosan’s antibacterial capabilities while the
added chlorines provide at least some inhibition to S. aureus. Ultimately, the derivatives
of triclosan did not have high inhibition rates at 4.0 ug/mL, but more experiments need to
be performed in order to determine their effects at higher concentrations and on different
species of bacteria. Hopefully, the data gathered and inferred from this experiment,
including several valuable dissolving ratios and laboratory techniques which were
discovered, will be implemented into future research on triclosan derivatives that will
lead to the discovery of compounds even more inhibitive against bacteria growth than
triclosan.
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The Effects of Triclosan Derivatives against the Growth of Staphylococcus Aureus
Background
Bacteria and Bacterial Diseases
Pneumonia, MRSA (Methicillin-Resistant Staphyloccus aureus), tetanus, anthrax,
plague—these infections and diseases have one major thing in common: they are all
caused by bacteria. Bacteria are single-celled organisms that contain peptidoglycan (a
unique structural component) in their cell walls. They generally have one of three typical
cell shapes: spherical, cylindrical, or spiral. They reproduce via binary fission—the
division of one cell into two (usually identical) daughter cells (Nester, Anderson,
Roberts, & Nester, 2007).
The human body provides an excellent host for many bacteria types, but not all
bacteria are harmful to humans. Internally and externally, the body is covered with
bacteria. In fact, one square centimeter of the human back contains approximately 1,000
organisms (including bacteria and fungi) whereas one square centimeter of the human
groin or armpit contains more than 10 million microorganisms (Nester et al., 2007).
These microorganisms compose what is known as the normal flora of the human body;
the normal flora consists of the microorganisms generally growing on healthy persons.
The bacteria which compose the normal flora, in many ways, actually help protect the
body from infection and disease by stimulating the immune system and preventing other
harmful bacteria from growing on or in the body (Nester et al.).
Unfortunately, however, some bacteria are harmful or pathogenic—capable of
causing disease. The problem occurs when bacteria have a parasitic relationship with the
body—also known as an infection. The infection itself, however, may or may not be
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noticeable. If, however, the infection leads to obvious damage to the body or bodily
functions, the infection is said to have become an infectious disease (Nester et al., 2007).
The diseases mentioned at the beginning of the introduction (pneumonia, tetanus,
anthrax, and plague) are all infectious diseases caused by bacteria.
One example of a bacterium which can cause infectious disease is Staphylococcus
aureus. S. aureus is part of the normal flora of bacteria present on the human body. In
fact, the bacterium dwells in mucous membranes of most individuals’ nostrils at some
point during their lives. This bacterium can get transferred to the skin (especially moist
skin) of individuals via their hands. Unfortunately, this bacterium is pathogenic and can
cause many different types of infections (primarily skin infections). Some of the
infections that S. aureus causes include folliculitis (infection of a hair follicle), food
poisoning, impetigo (skin infection), toxic shock syndrome, wound infections and several
other infectious diseases (Nester et al., 2007). Although usually not the cause of fatal
infectious disease, S. aureus can cause death especially in cases of toxic shock syndrome
which is caused by the release of toxins from the bacteria into the host. Toxic shock
syndrome usually involves hypotension, fever and the formation of a rash; these
symptoms can ultimately cause organ failure and/or lethal shock (McCormick, Yarwood,
& Schlievert, 2001). Thus, from this example of S. aureus, one can see how even normal
flora bacteria can cause severe infectious diseases.
Bacterial diseases have plagued the world for centuries. In Europe in the 14th
century, the bubonic plague killed an estimated twenty-five million people—
approximately one third to one half of the European population at the time (Thompson
and Combee, 1997). In many hospitals in Great Britain in the 19th century, patients would
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survive amputations of arms and limbs only to die shortly thereafter due to a disease
referred to as “hospitalism” (Bankston, 2005, p. 7-8), diseases apparently caused by
bacteria. Primarily due to the plague and “hospitalism,” millions have died from bacterial
infections over the past several centuries.
Antibiotics and Antiseptics
These bacterial diseases would no doubt have continued to plague modern-day
societies if it had not been for the discovery and development of antiseptics and
antibiotics. Antiseptics are chemicals—mild enough to be used on human skin—that are
used to kill or inhibit bacteria, fungi, or viruses (Nester et al., 2007). Joseph Lister is the
man credited with the discovery and promotion of the use of antiseptics and antiseptic
techniques. After studying the work of Louis Pasteur, Joseph Lister decided to treat a
young patient’s severe wound with linseed oil and carbolic acid in order to kill the germs
that could cause gangrene. The treatment worked. A cure had now been discovered for
hospitalism using carbolic acid and linseed oil as an antiseptic to prevent bacterial
infections! As a result of his use of this antiseptic, the death rate from major operations
plummeted to only 7.1 percent (Bankston, 2005). In addition, Lister helped to establish
several important antiseptic techniques involving increased sanitation and cleanliness in
hospitals to decrease the chance of bacterial infections. Surgeons operating today wear
masks and gloves largely as a result of Lister’s establishment of antiseptic techniques
(Bankston, 2005).
The discovery of antiseptics did much to prevent bacterial infections. The
discovery of antibiotics, however, did much not only to prevent bacterial infections but
also to treat and cure them. According to Nester et al. (2007), an antibiotic is “A
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compound naturally produced by mold or bacteria that inhibits the growth of or kills
other microorganisms” (p. 496). In 1928, Dr. Alexander Fleming discovered that a certain
mold growing on a petri dish seemed to have certain antibacterial effects. This discovery
soon led to the breakthrough of the antibiotic he named penicillin (Bankston, 2005). After
much experimentation, Penicillin G (a specific version of penicillin) began to be used to
treat many bacterial infections. Penicillin G was the first widely used antibiotic.
Following the discovery of penicillin, Selman Waksman discovered that a certain bacteria
produced an antibiotic called streptomycin. Thus a rapid search for more microorganisms
that produced antibiotics began. In the 1960s, researchers began to change certain
structural components of these early antibiotics to yield even more effective antibiotics—
e.g. ampicillin and methicillin (Nester et al.). Due to these new antibiotic discoveries, the
1960s were an exciting time period for microbiologists. These new antibiotics were truly
wonder drugs in that they could cure most bacterial infections. In fact, it was predicted
that with the discovery of these new antibiotics that one day bacterial infections would be
completely eliminated (Larson, 2007).
Antibiotics and antiseptics together form a class of drugs known as antimicrobials
which inhibit the growth of bacteria via several different mechanisms including
disrupting or interfering with cell wall synthesis, protein synthesis, nucleic acid synthesis,
metabolic pathways, and cell membrane integrity (Nester et al., 2007). For example,
triclosan, the antiseptic on which this study is focusing, is a phenolic compound (a
compound structurally similar to carbolic acid—also known as phenol) used in many
everyday products including toothpaste, soaps, and lotions (Nester et al.); triclosan
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inhibits bacterial fatty acid synthesis and thus inhibits bacteria growth by disrupting
bacterial cell membrane integrity (Ellison & Champlin, 2007).
Resistance to Antibacterial Compounds
It has been said: “Resistance to each new antibiotic…. is inevitable” (Larson,
2007, p. 436). Some bacteria have a natural resistance to certain antibiotics; this type of
resistance is called intrinsic or innate resistance. Other bacteria become resistant over
time due to mutations or due to obtaining new genetic material (e.g. the R plasmid); this
type of resistance is referred to as acquired resistance. As previously mentioned, the
discoveries of novel antibiotics led to the hope that bacterial infections would eventually
be eliminated. In fact, with the use and overuse of certain antibiotics, the non-resistant
strains of certain bacteria have been almost completely eradicated. Unfortunately, what
remains are resistant versions of bacteria. For example, at the first use of Penicillin G,
only 3% of S. aureus were resistant to the drug. Over time, however, the extreme use of
Penicillin G has all but eliminated non-resistant strains of S. aureus to the point that now
90% of S. aureus are resistant to this drug (Nester et al., 2007).
Antimicrobial resistance comes in many shapes and forms. Sometimes bacteria
produce enzymes which modify the drug in such a way as to inactivate it and thus inhibit
its toxic effects. Another method of resistance occurs when the antimicrobial’s target
molecule (the molecule to which the antimicrobial binds and inactivates) changes
structurally in such a way that the antimicrobial no longer binds to it. Bacteria can also
lower the amount of drug uptake by changing the structure of their outer membrane porin
proteins (proteins which determine the permeability of the bacteria’s membranes to
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certain molecules) or by amplifying the expression of their efflux pumps, which in turn
pump more of the drug back out of the cell (Nester et al., 2007).
Fortunately, there are quite often multiple antibiotics which can be used to treat
resistant forms of bacteria. For example, methicillin is another antibiotic (besides
Penicillin G) which can be used to treat S. aureus infections, but S. aureus is becoming
increasingly resistant to methicillin—MRSA (Larson, 2007). Vancomycin is an important
antibiotic often used to treat MRSA. Unfortunately, in 1997, a case of S. aureus resistant
to vancomycin was reported in Japan. Since then, there have been multiple reports of
vancomycin-resistant S. aureus (Walsh & Howe, 2002). This new resistance to
vancomycin is of special concern because vancomycin is often considered “the antibiotic
of last resort” (Nester et al., 2007, p. 191). This growing resistance in many different
types of bacteria (not just S. aureus) threatens to bring modern-day society back to the
“preantibiotic era” in regards to treating certain bacterial diseases (Larson, 2007, p. 435).
In addition to being resistant to some antibiotics, some bacteria are no longer
inhibited by certain antiseptics. For example, certain streptococci (group of bacteria
species) have cellular components innately resistant to triclosan. With this innate
resistance and the extreme usage of triclosan in many products, it is speculated that soon
there will be multiple strains of bacteria no longer inhibited by triclosan (Campbell &
Cronan, 2001). Therefore, it is imperative that new antiseptics are developed to help
prevent the growth of bacteria—especially bacteria resistant to certain antiseptics (e.g.
triclosan).
With this new threat of an antimicrobial-resistant world, what then can be done to
decrease the progression of antimicrobial-resistance in bacteria? Increasing personal
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hygiene practices, educating the public about proper use of antimicrobials, vaccinating
against certain diseases, limiting the use of antimicrobials in agriculture, lowering the
overuse and misuse of antimicrobials and increasing incentives to develop new
antimicrobials would all help slow the increase of antimicrobial resistance in bacterial
infections. Unfortunately, resistance cannot be totally eliminated. Therefore, it is essential
that new antimicrobials be continuously developed for prevention and treatment of
antimicrobial-resistant bacterial infections (Larson, 2007). The purpose of this study is to
evaluate four new antiseptics derived from triclosan.
Introduction
Staphylococcus aureus is a Gram-positive pathogenic bacterium known to cause
skin infections (Nester et al., 2007). Experiments have shown, however, that triclosan
(IUPAC name: 5-chloro-2-(2,4-dichlorophenoxy)phenol—Menoutis & Parisi, 2006,
Triclosan, para. 1)., an antibacterial compound used in many antiseptics and consumer
items (Campbell & Cronan, 2001), inhibits the growth of S. aureus (see Fig. 1).

Figure 1. Organic Structure of Triclosan (Menoutis & Parisi, 2006, Triclosan, para. 2).
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The bacterium Staphylococcus aureus was originally chosen for this experiment
for two important reasons: S. aureus is a pathogenic bacterium; and secondly, it grows
rapidly (and thus is easy to culture and use in experiments). During the course of this
experiment, however, the value of using S. aureus in this experiment increased due to
frequently reported MRSA (Methicillin-Resistant Staphylococcus aureus) outbreaks in
the local and national news. If some of these derivatives could inhibit S. aureus growth, it
is probable that they could also inhibit MRSA as well.
Triclosan inhibits the growth of S. aureus and other bacteria by inhibiting certain
enoyl ACP-reductases—essential enzymes involved in bacterial fatty acid synthesis
(Ellison & Champlin, 2007). Triclosan forms a tightly-bound, non-covalent ternary
complex with co-factor NAD(P)+ and an enoyl-ACP reductase encoded by fabI (fatty
acid biosynthesis gene I); this tight binding prevents the reductase from participating in
fatty acid synthesis—a form of competitive inhibition. The tight ternary complex is
achieved due to triclosan’s binding to the reductase’s active site—the site where the fatty
acid substrate normally binds (see Fig. 2). Triclosan’s binding site is located next to
NAD(P)+’s nicotinamide ring; thus, triclosan’s phenol ring interacts significantly with
NAD(P)+’s nicotinamide ring via hydrogen bonding leading to the formation of the
complete ternary complex (Escalada, Harwood, Maillard, & Ochs, 2005; Heath, Rubin,
Holland, Zhang, Snow, & Rock, 1999). Enonyl ACP-reductase is crucial for acyl chain
elongation in fatty acid synthesis in bacteria (Heath et al., 1999). Therefore, by inhibiting
this enzyme, triclosan inhibits the production of phospholipids which disturbs the
assembly of bacterial membranes which ultimately leads to the inhibition of bacterial
metabolism and growth (Ellison & Champlin, 2007; Heath et al., 1999).
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Figure 2. “The active site region of the FabI-NAD+-triclosan ternary complex. The
hydroxychlorophenyl ring stacks with the nicotinamide ring of the NAD+ with an
interplanar distance of 3.4 Å and contacts Tyr-146 and Tyr-156 on the protein. The
hydroxyl group of the ligand forms hydrogen bonds with phenol of Tyr-156 and with the
2’-hydroxyl of the NAD+ ribose. The 2,4-dichlorophenyl ring of triclosan sits in a
hydrophobic pocket in contact with Met-159. The 4-chloro substituent accepts a
hydrogen bond from the amide backbone amide nitgrogen of Ala-95” (Heath et al., 1999,
p. 11114, fig. 6).
Unfortunately, recent studies have shown that certain mutations in fabI as well as
overexpression of soxS, marA, and an efflux pump encoded by acrAB can all contribute
to triclosan resistance in bacteria. In fact, due to innate resistance to triclosan in some
bacteria and due to the heavy use and overuse of triclosan in everyday products, many
bacteria may be resistant to triclosan in the near future (Campbell & Cronan, 2001).
Therefore, it is essential that new antimicrobials be developed in order to destroy bacteria
that acquire resistance to triclosan.
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One possibility in the development of these new antimicrobials would be to
synthesize derivatives structurally similar to triclosan. Over the course of the past several
years, Professor McGibbon (professor of organic chemistry at Liberty University,
Lynchburg, VA) has synthesized several derivatives of triclosan. He added a benzene
ring via a dinitrogen double bond para to the alcohol on triclosan. The added benzene
ring in turn has anywhere from zero to four chlorines attached to it. Derivative 1 (burnt
orange) has chlorines attached to the added benzene ring at the 2,3,5,6 positions going
clockwise around the ring (the carbon attached to the nitrogen is in position 1—IUPAC
name: 5-chloro-2-(2,4-dichlorophenoxy)-4-(2,3,5,6-tetrachlorophenylazo)phenol —see
Table 1 and Fig. 3). Derivative 2 (rusty yellow and clumpy in appearance) has a chlorine
at the meta position (position 3) on the added ring (IUPAC name: 5-chloro-2-(2,4dichlorophenoxy)-4-(3-chlorophenylazo)phenol). Derivative 3 (small brown particles)
has just the extra benzene ring attached (no added chlorines—IUPAC name: 5-chloro-2(2,4-dichlorophenoxy)-4-(phenylazo)phenol). Derivative 4 (clumpy, claylike, dull,
yellow particles) has two chlorines attached to the added ring at the meta and para
positions (positions 3 and 4—IUPAC name: 5-chloro-2-(2,4-dichlorophenoxy)-4-(3,4dichlorophenylazo)phenol).
Table 1. Derivative Numbers Assigned to Various Triclosan Derivatives.
Derivative
number
Derivative 1
Derivative 2
Derivative 3
Derivative 4
Compound 5

Description of actual Triclosan Derivative
T with benzene ring attached with chlorines at positions 2,3,5,6 on the ring
(position 1 is the location of the attachment bond to Triclosan)
T with benzene ring attached with chlorine meta to attachment bond
T with benzene ring attached
T with benzene ring attached with 2 chlorines meta and para to attachment
bond
Triclosan (standard of comparison)
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A

B

C

D

Figure 3. Organic Structures of the Four Triclosan Derivatives. In all of the derivatives,
the added benzene ring is added via a dinitrogen double bond (-N=N-) to the 2nd ring of
triclosan para to the alcohol group. A) Derivative 1: The added ring has four chlorines
attached in positions 2,3,5,6 (ortho and meta positions). B) Derivative 2: The added ring
has one chlorine attached in the meta (3rd) position. C) Derivative 3: The added ring has
no chlorines attached. (Since this is the base structure of all the derivatives, the various
atoms are labeled in this figure.) D) Derivative 4: The added ring has two chlorines
attached in the meta and para (3rd and 4th) positions.

Effects of Triclosan Derivatives 15
A search of the relevant literature has revealed no tests on these triclosan
derivatives to date. Thus, one can easily see the potential importance of testing these
derivatives in this experiment especially considering the threat of growing bacterial
resistance against triclosan. If derivatives more inhibitive against bacteria than triclosan
could be synthesized, they could possibly be used against triclosan-resistant bacteria.
Therefore, four of Professor McGibbon’s derivatives (designated Derivatives 1-4) were
tested under the supervision of Dr. Hubbard (professor of microbiology at Liberty
University) for inhibitive capabilities against S. aureus.
Materials and Methods
Before any experiments were performed on triclosan and its derivatives, a sample
of Staphylococcus aureus was obtained from Dr. Hubbard. The S. aureus was streaked
for isolation on a Trypticase Soy Agar (TSA; Becton-Dickinson & Co., Sparks, MD)
plate (incubated at 37°C for approximately 1 day). A colony on the plate was also gramstained to ensure that the bacteria were indeed the gram-positive S. aureus. Two colonies
were then transferred into two test tubes of Trypticase Soy Broth (TSB—approximately
5mL each; Becton-Dickinson & Co.) to provide stock solutions for the duration of the
experiment. These colonies were incubated at 37°C for 1 day before being stored at 4°C
for the remainder of the experiment. Approximately halfway through the experiment, the
bacteria were re-isolated and two new broths of the bacteria were prepared and stored in a
similar fashion to be used for the remainder of the experiment.
Throughout this experiment, a modification of the Kirby-Bauer disc diffusion test
(Nester et al., 2007) was performed multiple times. In these tests, 0.1mL of S. aureus was
taken from the stock broth and spread onto a TSA plate. The 7mm paper discs were then
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soaked in their relative solutions for 5 sec. before being placed onto the TSA plate. The
plate was then incubated at 37°C for approximately 24 hours, and the zones of inhibition
around each disc were then measured.
A stock supply of triclosan and each derivative were obtained from Professor
McGibbon. He had synthesized each of the derivatives from triclosan in an organic
chemistry laboratory at Liberty University. The derivatives were designated Derivative 1,
2, 3, and 4 (see Table 1, p. 13).
Before triclosan or its derivatives’ solutions were prepared, 0%, 5%, 8%, 10%,
10.75%, 13%, 20%, and 25% acetone dilutions were all prepared; using a modification of
the Kirby-Bauer disc diffusion test, each of these acetone dilutions were tested against S.
aureus growth. Next, 20ug/mL, 10ug/mL, 5ug/mL, 4ug/mL, 2ug/mL, and 1ug/mL
triclosan solutions were all prepared by dissolving various amounts of triclosan in 20%
acetone solutions. These various concentrations of triclosan were then tested against the
growth of S. aureus once again using a modification of the Kirby-Bauer disc diffusion
test.
Next, 4ug/mL solutions of triclosan and the various triclosan derivatives were
prepared. In preparing the triclosan solution, 1.0mg of triclosan was dissolved in a
100mL 50% acetone/50% deionized water solution. The solution was lightly heated and
intensely stirred for 15 minutes. Another 150mL of deionized water was added
approximately 10 minutes into the stirring to yield a 20% acetone solution. Each of the
derivatives was prepared in a similar fashion to yield a 4ug/mL 20% acetone solution of
each compound. These solutions were sealed and stored at room temperature for the
duration of the experiment.
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Finally, several Kirby-Bauer disc diffusion tests were performed testing triclosan
and its derivatives against S. aureus growth. In the first of these tests, triclosan and
Derivatives 1-2 were tested against the bacteria growth. In the second experiment, two
Kirby-Bauer disc diffusion tests were performed testing triclosan and all four derivatives
against S. aureus growth. In the final experiment, five Kirby-Bauer disc diffusion tests
were performed testing triclosan and all four derivatives against the bacteria growth.
Results
In the experiment with the various acetone/water solutions, the 0%, 5%, 8%, 10%,
10.75%, 13%, and 20% acetone solutions did not exhibit resistance/inhibition to S.
aureus. The 25% acetone solution did inhibit the growth of S. aureus; it produced a 9mm
(diameter) zone of inhibition.
The results of the experiment with the various concentrations of triclosan on the
two TSA plates are included in the table and graph below. Table 2 lists the zones of
inhibition of each triclosan concentration on each TSA plate. Figure 4 plots the average
zones of inhibition of the various concentrations of triclosan from both plates (in 20%
acetone solution).
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Table 2. Inhibition Zones of Various Concentrations of Triclosan.
Inhibitor
(compound and
concentration)
Water
20% acetone
Triclosan
(1ug/mL)
Triclosan
(2ug/mL)
Triclosan
(4ug/mL)
Triclosan
(5ug/mL)
Triclosan
(10ug/mL)
Triclosan
(20ug/mL)

Plate 1:
Inhibition
zone
(mm)
0
0

Plate 2:
Inhibition
zone
(mm)
0
0

0

1

0

7

7

14

12

14

13

12

13

18

.
Figure 4. Inhibition Zones of the Different Concentrations of Triclosan in 20% Acetone
Solutions. Generally, the zones of inhibition increased in diameter as the concentration of
the triclosan solution increased; at a concentration of 5ug/mL, the increase in the zones of
inhibition began to level off.
The results of the early experiment with Derivatives 1-2 and triclosan are seen in
Table 3. Triclosan produced a zone of inhibition with a 20mm diameter. Derivatives 1
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and 2 produced 8mm zones of inhibition (measured at approximately 22 hours). At 43
hours, Derivative 2’s zone of inhibition had shrunk to 7mm (see Table 3) while
triclosan’s and Derivative 1’s zones of inhibition had remained the same.
Table 3. Inhibition Zones of Derivative 1, Derivative 2, and Triclosan. D1 & D2 did not
display nearly as much inhibition as triclosan did, and D2’s zone of inhibition actually
shrunk over time.
Derivative
Derivative 1
Derivative 2
Triclosan

Inhibition
Zones at 22
hours (mm)

Inhibition
Zones at 43
hours (mm)
8
8
8
7
20
20

In the first experiment with all four derivatives and triclosan, Derivative 1
produced zones of inhibition with 8 mm and 7 mm diameters on Plates 1 and 2
respectively (see Table 4). Derivative 2 produced zones of inhibition with 7 mm
diameters on both plates. Derivative 3 had no zone of inhibition on Plate 1 and a 7mm
zone of inhibition on Plate 2. Derivative 4 produced 8mm and 7mm zones of inhibition
on Plates 1 and 2 respectively. Finally, Derivative 5 (triclosan) produced 26mm and
19mm zones of inhibition on Plates 1 and 2 respectively.
The results of this experiment on Derivatives 1-4 and triclosan (labeled 5) are
summarized by Table 4 and Figures 5-9 below. Figure 9 is a comparison of the average
inhibition zones of Derivatives 1-4 and triclosan (Compound 5). The results clearly show
that none of the derivatives are nearly as inhibitive against the growth of S. aureus as
triclosan is.
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Table 4. Inhibition Zones of Various Triclosan Derivatives. None of the derivatives were
as inhibitive against S. aureus as triclosan. Although most of the derivatives showed some
inhibition, on plate 1, D3 showed no inhibition at all against S. aureus growth.
Derivative
Derivative 1
Derivative 2
Derivative 3
Derivative 4
Triclosan (5)

Plate 1:
Inhibition
Zone (mm)
8
7
0
8
26

Plate 2:
Inhibition
Zone (mm)
7
7
7
7
19

Figure 5. Inhibition Zones of Various Triclosan Derivatives (Plate 1). Triclosan is
pictured at the bottom, and the derivatives are pictured in order (D1-D4) clockwise
around the plate starting at triclosan. Notice the lack of inhibition in Derivative 3.
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.
Figure 6. Comparison of the Inhibition Zones of Triclosan Derivatives (Plate 1). As
noted in Table 3, D3 showed no inhibition against S. aureus growth.

Figure 7. Inhibition Zones of Various Triclosan Derivatives (Plate 2). Triclosan is
pictured at the bottom; the derivatives are pictured in order (D1-4) clockwise around the
plate starting at triclosan.
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.
Figure 8. Comparison of the Inhibition Zones of Triclosan Derivatives (Plate 2). On this
plate, D3 did show some inhibition against S. aureus.

.
Figure 9. Comparison of the Average Inhibition Zones of Triclosan Derivatives. This graph
takes the average of the zones of inhibition of triclosan and each of the derivatives from the
two TSA plates.
In the final experiment with the 5 TSA plates, the results were observed to confirm
the results of the main experiment (See Fig. 5-9). The results, however, were not physically
measured.
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Discussion
Introductory Summary of Findings
The results indicate that, as tested in this experiment, none of the derivatives were
as inhibitive as triclosan against the growth of S. aureus (The reason that no results were
physically measured in the final experiment was that the results appeared to be virtually
identical to the results of the previous experiments and clearly indicated that the
derivatives were not as inhibitive as triclosan). Fortunately, several observations and
laboratory techniques were discovered and developed during the experimental
procedures. It is hoped that these observations and techniques will aid in future research
on triclosan derivatives.
Inhibition by Triclosan Is Greater than All Derivatives
As tested in this experiment, none of the derivatives were as inhibitive as
triclosan. In fact, none of the derivatives produced zones of inhibition even half the
average diameter of triclosan’s zone of inhibition, and in one experiment, Derivative 3
showed no inhibition at all against the bacteria growth (see Fig. 6, p. 21).
One possible explanation for the derivatives’ small zones of inhibition would be
that the derivatives may not dissolve (nor stay dissolved) as well as triclosan. The
derivatives, structurally, are less polar than triclosan due to the addition of the extra
benzene ring. Therefore, it would be more difficult to dissolve them in the primarily polar
20% acetone solution (80% deionized water). It is possible that when the discs soaked in
the derivative solutions were placed onto the TSA plate that the derivatives did not stay
completely dissolved; therefore, as the acetone/water solution diffused outward onto the
agar, the derivatives could have crystallized onto the disc and not diffused out with the
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solution, therefore producing only small zones of inhibition against S. aureus. Although
this proposition is only a hypothesis, certain observations during the experiment seem to
support it. For example, the derivatives proved more difficult to dissolve than triclosan, a
fact which indicates that the derivatives would most likely come out of solution more
easily than triclosan. Two simple ways to test this hypothesis would be to perform a
minimum inhibitory concentration (MIC) test (Nester et al., 2007) or to test for a bacteria
that can tolerate higher levels of acetone (30-50% solutions) and to repeat this KirbyBauer disc diffusion test using compounds dissolved in these more concentrated acetone
solutions—the higher acetone concentration should ensure the derivatives stay dissolved.
Another way to test this hypothesis would be to dissolve the derivatives in the 20%
acetone solution, then to make an agar directly from this solution, and finally to test if S.
aureus is capable of growing on this agar containing the derivative.
Assuming that it was not the derivatives’ insolubility that caused their small zones
of inhibition, there was another observation that may explain the derivatives’ apparent
lack of significant inhibition against S. aureus. Figures 6 and 9 show that the benzene
ring added to triclosan by itself (no chlorines attached to the ring—Derivative 3) seems to
inactivate triclosan’s inhibitive capabilities toward S. aureus. But as more chlorines are
attached to the added ring, the inhibition seems to be slightly increased as compared to
just the added ring by itself (see Fig. 5-9, p. 20-22). Therefore, a possible future
experiment would be to synthesize triclosan derivatives that consist of chlorines added to
one (or both) of the two benzene rings of triclosan itself instead of adding another
benzene ring (with attached chlorines) to triclosan. These compounds may prove to be
more inhibitive than the derivatives tested in this experiment.
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Based on these observations and hypotheses, recommendations for future research
would therefore include more tests performed with Derivatives 1-4 not only against S.
aureus (using 4ug/mL and higher concentrations as well) but also against other
pathogenic bacteria. In addition, compounds should be synthesized based on the
description above (with chlorines added to the triclosan benzene rings) and tested for
antibacterial capabilities. Finally, to determine the inhibitory capabilities of all of these
derivatives, other antimicrobial tests (see above paragraphs), including a minimum
inhibitory concentration (MIC) test, should be performed.
Methodological Benefits of Study
Despite the negative results of this experiment, several beneficial observations
and techniques developed during the course of the experiment could aid in future efforts
to develop/discover more effective antiseptic compounds. Well over half the time
devoted to experimental methods was spent primarily on developing effective
procedures. These procedures were used to provide stock solutions and to determine
ratios and concentrations to use during the main experiment. The observations and
discovered techniques which have been established from this study will prove extremely
helpful in future research on triclosan.
Because triclosan is insoluble in a purely aqueous solution, it was determined that
a partial acetone solution would be used to dissolve triclosan and its derivatives.
Therefore, the original experiment testing various concentrations of acetone against S.
aureus growth was performed to determine the maximum concentration of acetone that
could be used to dissolve the compounds. Since 25% acetone concentration showed a
complete inhibition against bacteria growth and the 20% acetone concentration showed
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no inhibition against bacteria growth, it was determined to use a 20% acetone solution for
dissolving triclosan and its derivatives.
To determine the concentration of triclosan and its derivatives to use for the
comparison experiment, the experiment testing the various concentrations of triclosan
(1ug/mL-20ug/mL) was performed. Figure 4 clearly indicates that increasing the
concentration of triclosan increases the zones of inhibition significantly up until a
concentration of 5ug/mL is reached; at this point, the zones of inhibition begin to level
off even if the triclosan concentration is doubled or quadrupled. Therefore, it was
determined that 4ug/mL would be the best concentration to use for a comparison study
between triclosan and its derivatives.
Despite using a low concentration for the experiment, dissolving the derivatives
still proved extremely difficult. Therefore, at the recommendation of Dr. Hubbard, the
compounds were originally dissolved in a 50% acetone solution by stirring on low heat,
and more deionized water was added approximately 10 minutes into stirring to bring the
acetone concentration down to 20% and the compound concentration down to 4ug/mL.
This method proved efficient in dissolving the compounds and should be used in future
efforts to dissolve triclosan and/or its derivatives.
Conclusion
In conclusion, although the tests performed in this study indicate that none of the
derivatives were nearly as inhibitive as triclosan itself, several valuable insights were
gained. First of all, it was discovered that a 4ug/mL 20% acetone solution of each
compound was the best concentration for dissolving triclosan and its derivatives and
performing comparison experiments. Secondly, dissolving the compounds into a 50%
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acetone solution (stirring on low heat) and diluting to a 20% acetone solution (while still
stirring on low heat) proved far more effective than dissolving the compounds straight
into a 20% acetone solution. Finally, although none of these derivatives seem to hold
much promise as components of future antiseptics, there is hope that other derivatives
will be synthesized by adding chlorines directly to triclosan (as described in the
Discussion section) and that these derivatives will be subsequently tested for antibacterial
capabilities. All three of these observations could prove extremely useful in future
experiments with triclosan derivatives. With time and effort, antibacterial compounds
even more inhibitive than triclosan may be discovered to aid in the battle against
pathogenic bacteria.
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